Cliniworks claims AccelFind can accelerate patient recruitment

- Last updated on GMT

Software developer CliniWorks says data-mining is key to addressing trial sector’s “Achilles Heel,” patient recruitment.

The comments follow CliniWorks’ receipt of the judge's choice award at Bio-IT World's 2011 Best Practices Award competition for its AccelFind data mining and patient screening software.

AccelFind is natural-language processing based analysis platform designed solely to analyse medical terminology. The system first converts medical records into a usable format and then searches them according to a trial's inclusion and exclusion criteria.

CEO Nitzan Sneh told “AccelFind helps researchers and investigators to quickly and securely find matching outcomes, evidence and cases against clinical study inclusion and exclusion criteria out of millions of medical records in seconds​.”

Sneh, who founded Massachusetts, US-based CliniWorks, added that the ability to automate such searchers and cut months off the patient recruitment process is just one of the ways AccelFind differs from other systems.

Current recruitment applications are not connected to the entire population of an institution at the medical records level but only to patients (via media and other sources) or relatively limited populations available to CROs and research institutions.

Most importantly we provide access to Investigators and their potential specific eligible patients, while most other applications can only provide only investigators or volunteering patients​. “

The platform, which was launched last year as a software as a service (SaaS system, has been used in more than 100 Phase II and III studies by both contract research organizations (CRO) and pharmaceutical sponsors.

Patient Recruitment Outsourcing

Accelerating patient recruitment will be a key focus for’s event “Patient Recruitment Outsourcing” event in Boston on September 26 and 27.

"Patient Recruitment Outsourcing 2011 will take a strategic look at outsourcing of patient recruitment, discussing when to outsource, who to partner with and looking at how outsourcing can overcome the challenges of working in rare indications, in global locations or engaging with patients already overwhelmed with trial information."

Click here​ to sign up for the event.

Related news

Show more

Related products

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...


Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...


Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

Related suppliers